Rollins Emily
- SEC CIK
- 0001847014
In the past year, 5 open-market sale filings worth $653.5K and no purchases.
Current role at each company
- XMTR Xometry, Inc.Directoras of Aug 21, 2026
- DLB Dolby Laboratories, Inc.Directoras of Apr 3, 2026
- SNCE Science 37 Holdings, Inc.Other: Former Directoras of Mar 12, 2024
- MCFE McAfee Corp.Directoras of Mar 3, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $653.5K
- 5 filings
- Net
- −$653.5K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Rollins Emily as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XMTR Xometry, Inc.
Director17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 (view filing)4:28 PM ET | Aug 19 | 2 days | Rollins EmilyDirector | SSaleClass A Common Stock | −5.00K | $84.31 | −$421.5K | −24.8%15.1K after | 3 lots10b5-1 |
| Apr 3, 2026 (view filing) | Apr 1 | 2 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $42.02 | −$42.0K | −6.2%15.1K after | 10b5-1 |
| Jan 6, 2026 (view filing) | Jan 2 | 4 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $61.86 | −$61.9K | −8.0%11.5K after | 2 lots10b5-1 |
| Nov 12, 2025 (view filing) | Nov 10 | 2 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $68.02 | −$68.0K | −8.0%11.5K after | 3 lots10b5-1 |
| May 9, 2025 (view filing) | May 9 | Same day | Rollins EmilyDirector | SSaleClass A Common Stock | −10.0K | $30.70 | −$308.3K | −47.5%11.1K after | 2 lots |
| Apr 8, 2025 (view filing) | Apr 7 | 1 day | Rollins EmilyDirector | SSaleClass A Common Stock | −2.00K | $20.66 | −$41.3K | −11.0%16.1K after | 3 lots10b5-1 |
| Nov 12, 2024 (view filing) | Nov 7 | 5 days | Rollins EmilyDirector | SSaleClass A Common Stock | −3.73K | $29.49 | −$110.0K | −23.0%12.5K after | 2 lots10b5-1 |
| Jan 29, 2024 (view filing) | Jan 26 | 3 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $32.39 | −$32.4K | −8.5%10.8K after | 10b5-1 |
| Jan 2, 2024 (view filing) | Dec 29, 2023 | 4 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $36.83 | −$36.8K | −8.5%10.8K after | 2 lots10b5-1 |
| Dec 5, 2023 (view filing) | Dec 1 | 4 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $25.04 | −$25.0K | −8.5%10.8K after | 2 lots10b5-1 |
DLB Dolby Laboratories, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2026 (view filing) | Apr 1 | 2 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $60.08 | −$60.1K | −7.4%12.5K after | 10b5-1 |
| Feb 3, 2025 (view filing) | Jan 30 | 4 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $84.90 | −$84.9K | −13.3%6.49K after | 10b5-1 |
| Mar 5, 2024 (view filing) | Mar 1 | 4 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $80.88 | −$80.9K | −11.8%7.49K after | |
| May 10, 2023 (view filing) | May 8 | 2 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $84.70 | −$84.7K | −15.3%5.54K after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $82.04 | −$82.0K | −13.3%6.54K after | |
| Aug 12, 2022 (view filing) | Aug 10 | 2 days | Rollins EmilyDirector | SSaleClass A Common Stock | −1.00K | $80.00 | −$80.0K | −19.1%4.25K after |